Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
about
Insomnia pharmacotherapyTreatment-refractory anxiety; definition, risk factors, and treatment challengesPharmacological treatment of anxiety disorders: current treatments and future directionsPsychiatric disorders and sleepPharmacotherapy Treatment Options for Insomnia: A Primer for CliniciansThe impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trialEffects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in ratsLow-dose doxepin for the treatment of insomnia: emerging data.The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study.A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.The association between insomnia severity and healthcare and productivity costs in a health plan sample.Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youthModeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind studyAtypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample.Effects of Exercise on Sleep Among Young Women With Generalized Anxiety Disorder.Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity.A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future HorizonsInsomnia in older adults with generalized anxiety disorder.Algorithms for the assessment and management of insomnia in primary care.Emerging drugs for insomnia: new frontiers for old and novel targets.Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Pharmacotherapy of insomnia.Agomelatine in treating generalized anxiety disorder.Linkages between insomnia and suicidality: prospective associations, high-risk subgroups and possible psychological mechanisms.New Developments in Insomnia Medications of Relevance to Mental Health Disorders.World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction.An Update on the Use of Sedative-Hypnotic Medications in Psychiatric Disorders.Insomnia Management in the Australian Primary Care Setting.Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates.In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.New guidelines for diagnosis and treatment of insomnia.The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks.Prevalence of Insomnia and Associated Factors in Outpatients With Generalized Anxiety Disorder Treated in Psychiatric Clinics.Chronic Pain and Sleep Disorders in Primary Care.
P2860
Q24623757-7C227704-138C-42AC-9EBA-0A00F11F84A2Q26798229-BC8913BD-D735-487B-8F98-EACA5C942D64Q26851461-9D7700F6-BFD2-46D4-9664-CD82932711ADQ27007685-E267537C-EB19-47E4-9FF8-2AF5395D3B4EQ28077832-927DBEAF-A6D1-4CE9-8675-C0F28B908D3CQ30301208-1E507E03-7ACF-41AF-BD9B-A662BC94A6B8Q30475046-58F201A5-C389-4CE4-8A16-F29692806BC7Q33460649-E948CDB9-D841-447B-BB80-4C5BE59E8189Q33586991-1FA246F6-1504-4BCB-A533-D37C3A33577FQ33587570-80CDACBB-2832-4CEC-9718-5775C5CE25ABQ34024109-5E11FB5F-8073-40A5-9700-8DAF05C5C323Q34727018-A70C0AAB-33D9-4A83-A28F-7F0600C51FF3Q35003407-296B9AFF-1CAF-4DED-9020-84971860A8B1Q35761878-06669038-9F7A-4D81-A5B7-25DA851C8BF5Q35939600-C940CDAC-E6E3-498D-B10E-C1B22F185710Q36198401-39E45816-0550-4280-A288-C47C046F169AQ36205791-B574EB2E-7AE9-4AF1-98D5-CD59C04F5420Q36238104-BBDFA245-1838-475A-AB90-24C40BFEAB68Q36262777-3008EBE3-1ADE-479F-8BC9-4CDF67097E4AQ36419739-11D2C0CA-A426-4214-9CE3-D4A30A64DA37Q36897384-0D58EB24-2406-4A10-BC59-87B54567CBA9Q37149325-C7170320-D9B1-445D-A6EC-CFB5A2AE3627Q37234251-FC46A17C-5604-45CD-87DC-B9C8409C589FQ37423760-CBA30792-9247-41D4-8B65-22360D90B43DQ37587178-00F55884-44E9-4C4C-8E35-41B4D7648541Q37639811-A3733477-2481-4275-9355-24ED2FE7A229Q37653402-0A9AAEF9-3ECB-4C22-9847-7E4321A20E9AQ38009370-54921577-A388-4F03-A33D-2FFCA622EBBAQ38207149-7774B98F-BE97-4C45-8E13-CB8E64AF1587Q38217282-C2D556C6-104B-477B-9179-71586EA60044Q38645553-CB8BB535-A19D-4E59-850B-D605CF4446C9Q38646237-DC419D4E-0A89-4DE2-AE8F-A9E621A45517Q38841819-B389EC93-EBBB-4A51-B0D3-35F0C9D8C44CQ39015232-D5080DE3-82A9-494A-8D8F-837A88753279Q40264491-2493154F-7164-4E9B-A66A-A0C1DCA05078Q41570637-47F275D2-9D71-4B42-9DFE-564491AA803FQ42929690-EA0149F4-5045-4F21-BAB7-59259D103F7EQ43715889-ECE38F8A-E791-42EF-8618-3389764DA20EQ47431784-8323B85C-3BCA-443B-83D3-585B0218B372Q48094022-00D2D265-7F2E-4FF7-BEBE-D6F055DD1B54
P2860
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Eszopiclone coadministered wit ...... generalized anxiety disorder.
@en
type
label
Eszopiclone coadministered wit ...... generalized anxiety disorder.
@en
prefLabel
Eszopiclone coadministered wit ...... generalized anxiety disorder.
@en
P2093
P1433
P1476
Eszopiclone coadministered wit ...... generalized anxiety disorder.
@en
P2093
Gustavo Kinrys
Holly Huang
James Roach
Kendyl Schaefer
Mark Pollack
Ranga Krishnan
Robert Rubens
Thomas Roth
P304
P356
10.1001/ARCHPSYC.65.5.551
P407
P577
2008-05-01T00:00:00Z